Table 2.
Preceding lines of therapy
| Therapy | Gatipotuzumab (n = 149), n (%) | Placebo (n = 64), n (%) | Total, n (%) |
|---|---|---|---|
| Chemotherapy | 149 (100.0) | 64 (100.0) | 213 (100.0) |
| Hormone therapy | 4 (2.7) | 0 | 4 (1.9) |
| Radiotherapy | 8 (5.4) | 2 (3.1) | 10 (4.7) |
| Other | 20 (13.4) | 12 (18.8) | 32 (15.0) |
| Surgery | 145 (97.3) | 63 (98.4) | 208 (97.7) |
| Best overall response to any chemotherapy | |||
| Complete response | 102 (68.5) | 32 (50.0) | 134 (62.9) |
| Partial response | 40 (26.8) | 19 (29.7) | 59 (27.7) |
| Stable disease | 7 (4.7) | 12 (18.8) | 19 (8.9) |
| Not assessable | 0 (0.0) | 1 (1.6) | 1 (0.5) |